These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6933760)

  • 21. [Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies].
    Sánchez Fayos J; Prieto E; Chica Gullón E
    Sangre (Barc); 1998 Apr; 43(2):121-6. PubMed ID: 9656773
    [No Abstract]   [Full Text] [Related]  

  • 22. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis.
    Konoplev S; Hsieh PP; Chang CC; Medeiros LJ; Lin P
    Hum Pathol; 2007 Dec; 38(12):1760-3. PubMed ID: 17707884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disorders.
    Taetle R; Guittard JP; Mendelsohn JM
    Exp Hematol; 1980 Nov; 8(10):1190-1201. PubMed ID: 6971757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
    Haferlach T; Kern W; Schnittger S; Schoch C
    Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dysmegakaryocytopoiesis and dysthrombopoiesis in myeloproliferative syndromes].
    Brière J; Kiladjian JJ; Peynaud-Debayle E
    C R Seances Soc Biol Fil; 1996; 190(5-6):533-9. PubMed ID: 9074718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloproliferative disorder with lytic osseous lesions and chromosomal anomalies.
    Rudders RA; Kilcoyne RF
    Am J Clin Pathol; 1974 May; 61(5):673-9. PubMed ID: 4524224
    [No Abstract]   [Full Text] [Related]  

  • 31. Myelofibrosis and megakaryoblastic transformation of chronic myelogenous leukemia associated with intrinsic platelet dysfunction: hematological, histological and ultrastructural findings.
    Cortelazzo S; D'Emilio A; Battista R; Ricciardi O; Dini E; Visonà A; Montaguti A; Pennelli N
    Haematologica; 1984; 69(6):671-81. PubMed ID: 6441743
    [No Abstract]   [Full Text] [Related]  

  • 32. The pathogenesis of myeloproliferative syndromes.
    Adamson JW; Fialkow PJ
    Br J Haematol; 1978 Mar; 38(3):299-303. PubMed ID: 346048
    [No Abstract]   [Full Text] [Related]  

  • 33. Myeloproliferative disease in the dog and cat: definition, aetiology and classification.
    Evans RJ; Gorman NT
    Vet Rec; 1987 Nov; 121(19):437-43. PubMed ID: 3424614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of permanent marrow ablation to induce a myeloproliferative disorder in rabbits.
    Adler SS; Trobaugh FE; Knospe WH
    Biomedicine; 1975 Dec; 23(10):403-5. PubMed ID: 1222216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [XXXIV. Spontaneous development of pancytopenia during the course of an untreated chronic myelosis].
    Bundschu HD; Wilmanns W
    Med Welt; 1968 Apr; 17():1151-4. PubMed ID: 5248441
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nosology of myeloproliferative disorders].
    Stobbe H
    Z Gesamte Inn Med; 1980 May; 35(9):357-60. PubMed ID: 6933760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease.
    Gilbert HS
    Prog Clin Biol Res; 1984; 154():3-17. PubMed ID: 6382299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloproliferative diseases in childhood.
    Nix WL; Fernbach DJ
    Am J Pediatr Hematol Oncol; 1981; 3(4):397-407. PubMed ID: 6174053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.